SCHEMBL6806897

SCHEMBL6806897

NC(=O)c1cccc2nc(-c3cccnc3NCCN3CCCCCC3)[nH]c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.50
PIM3 Q86V86 2/20 0.50
AURKB Q96GD4 2/20 0.50
MKNK2 Q9HBH9 2/20 0.50
FLT3 P36888 1/20 0.50
BRSK1 Q8TDC3 1/20 0.50
ELANE P08246 1/20 0.42
PARP1 P09874 6/20 0.41
DHODH Q02127 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ACP1 P24666 1/20 0.39
TOP2A P11388 1/20 0.39
USP2 O75604 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CSF1R P07333 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805265 1.00 PIM1 (0.50) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6805715 0.99 PIM1 (0.51) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6811032 0.95 PIM1 (0.45) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6805548 0.95 PIM1 (0.45) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6807423 0.94 PIM1 (0.45) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6806668 0.92 PIM1 (0.45) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6805712 0.92 PIM1 (0.47) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6801493 0.89 AURKB (0.42) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6806656 0.87 CARM1 (0.42) PIM1PIM3AURKBMKNK2FLT3
SCHEMBL6805777 0.86 PRKD3 (0.53) PIM1PIM3AURKBMKNK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696437-B1 Heterocyclically substituted benzimidazoles, the production and application thereof ABBOTT GMBH & CO. KG (DE) 2004-02-24 US disclosed